ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.064,06
0,91%
Dow Jones
38.224,92
0,85%
Euro vs US Dollar
1,07278
0,09%
Bitcoin
59.167,83
1,59%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Galectin Therapeutics Inc (GALT)

  7. Galectin Therapeutics Inc (GALT) News

GALT Galectin Therapeutics Inc

3,41
-0,09 (-2,57%)
Zuletzt aktualisiert: 20:47:42
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Galectin Therapeutics Inc GALT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,09 -2,57% 3,41 20:47:42
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,51 3,23 3,54 3,50
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
04.3.202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202414:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202322:15EDGAR2Form 8-K - Current report
07.12.202317:42EDGAR2Form 8-K - Current report
01.12.202322:50EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
01.12.202322:38EDGAR2Form SC 13D/A - General statement of acquisition of..
01.12.202314:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202323:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202315:21EDGAR2Form 8-K/A - Current report: [Amend]
13.11.202314:45GLOBEUPDATE – Galectin Therapeutics Reports Financial Results for..
13.11.202314:00GLOBEGalectin Therapeutics Reports Financial Results for the..
13.11.202313:55EDGAR2Form 8-K - Current report
13.11.202313:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202313:00GLOBEGalectin Therapeutics to Share Five Scientific Presentations..
31.10.202321:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.10.202314:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
16.10.202314:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.10.202314:00GLOBEGalectin Therapeutics Announces Nomination of Dr. Benjamin..
06.10.202314:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06.10.202314:03EDGAR2Form DEF 14A - Other definitive proxy statements
03.10.202314:00GLOBEGalectin Therapeutics Reports the Positive Outcome of the..
02.10.202313:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.9.202320:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.9.202314:00GLOBEGalectin Therapeutics to Present Update on its Belapectin..
18.9.202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.9.202322:38EDGAR2Form 144 - Report of proposed sale of securities
11.9.202314:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
07.9.202318:00GLOBEGalectin Therapeutics to Present Data on Liver Cirrhosis at..
01.9.202313:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.8.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202314:00GLOBEGalectin Therapeutics Reports Financial Results for the..
14.8.202313:55EDGAR2Form 8-K - Current report
14.8.202313:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31.7.202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.7.202313:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.7.202314:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.7.202313:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
GALT
Galectin Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten